New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Legend Biotech Corporation
LEGN
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

3B

Biotechnology

Next Earning date - 12 May 2025

3B

Biotechnology

Next Earning date - 12 May 2025

36.95USD

Shape-0.77 ( -2.04%)
Market Closed (as of Mar 21, 20:00 EDT)
favorite-chart

Relative Strenght

35
favorite-chart

Volume Buzz

15%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

39%

Quote Panel

Shape
Updated March 24, 2025
1W -2.46 % 1M -0.16 % 3M 12.72 % 1Y -34.79 %

Key Metrics

Shape
  • Market Cap

    3.39B


  • Shares Outstanding

    91.82M


  • Share in Float

    90.57M


  • Dividende

    0


  • Earning Date

    12 May 2025


  • Price Target

    36.95


  • Average Volume

    1.22M


  • Beta

    0.195


  • Range

    30.17-60.87


  • Industry

    Biotechnology


  • Website

    https://www.legendbiotech.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

LEGN

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$1B

Shape447%

2025-Revenue

$0.42

Shape-397%

2025-EPS

$853M

Shape-1726%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

75.00(102.98%)

Number of analyst

1

Last analyst upgrade/downgrade

Deutsche Bank

initialise

Previous: Not converted

2024-05-23

Now: Buy

Scotiabank

upgrade

Previous: Sector Perform

2024-04-17

Now: Outperform

Cantor Fitzgerald

initialise

Previous: Not converted

2024-04-03

Now: Overweight

William Blair

initialise

Previous: Not converted

2023-05-25

Now: Market Perform

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

N/A

-0.40
vs -0.24

Q2.23

arrow
arrow

N/A

-0.27
vs NA

Q3.23

arrow
arrow

N/A

-0.17
vs -0.41

Q4.23

arrow
arrow

N/A

-0.40
vs -0.85

Q1.24

arrow
arrow

N/A

-0.16
vs -0.40

Q2.24

arrow
arrow

N/A

-0.05
vs -0.27

Q3.24

arrow
arrow

N/A

-0.34
vs -0.17

Q4.24

arrow
arrow

N/A

-0.15
vs -0.40

Q1.25

arrow
arrow

N/A

-0.21
vs -0.16

Q2.25

arrow
arrow

N/A

-0.14
vs -0.05

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

-11%

36.3M  vs 40.8M

Q2.23

arrow
arrow

+513%

73.3M  vs 12M

Q3.23

arrow
arrow

+251%

96M  vs 27.4M

Q4.23

arrow
arrow

+188%

79.5M  vs 27.6M

Q1.24

arrow
arrow

+159%

94M  vs 36.3M

Q2.24

arrow
arrow

+154%

186.5M  vs 73.3M

Q3.24

arrow
arrow

+67%

160.2M  vs 96M

Q4.24

arrow
arrow

+135%

186.5M  vs 79.5M

Q1.25

arrow
arrow

+104%

192M  vs 94M

Q2.25

arrow
arrow

+29%

240.3M  vs 186.5M

Return on EquityShape

status-upQoQ

Q1.23

arrow
arrow

-17%

-0.17
vs -0.18

Q2.23

arrow
arrow

-14%

-0.14
vs -0.17

Q3.23

arrow
arrow

-5%

-0.05
vs -0.14

Q4.23

arrow
arrow

-12%

-0.12
vs -0.05

Q1.24

arrow
arrow

-5%

-0.05
vs -0.12

Q2.24

arrow
arrow

-2%

-0.02
vs -0.05

Q3.24

arrow
arrow

-11%

-0.11
vs -0.02

Q4.24

arrow
arrow

+3%

0.03
vs -0.11

Institutionnal OwnershipShape

status-upQoQ

Q1.23

arrow
arrow

171

171
vs 182

-6%

Q2.23

arrow
arrow

203

203
vs 171

19%

Q3.23

arrow
arrow

217

217
vs 203

7%

Q4.23

arrow
arrow

228

228
vs 217

5%

Q1.24

arrow
arrow

212

212
vs 228

-7%

Q2.24

arrow
arrow

190

190
vs 212

-10%

Q3.24

arrow
arrow

218

218
vs 190

15%

Q4.24

arrow
arrow

225

225
vs 218

3%

Earnings Growth

Latest News

LEGN

seekingalpha.com

14 hours ago